What Happened?
Seattle, -based Neoleukin Promoted Donna Cochener as Interim Chief Executive Officer, Senior Vice President of Legal and General Counsel
Date of management change: April 03, 2023
Seattle, -based Neoleukin Promoted Donna Cochener as Interim Chief Executive Officer, Senior Vice President of Legal and General Counsel
Neoleukin Therapeutics emerged from the University of Washington Institute for Protein Design in January of 2019. We are creating next generation immunotherapies using breakthrough de novo protein design technology. We use natural protein complexes as inspiration to develop custom designed proteins with superior pharmaceutical properties.
Donna Cochener is Interim Chief Executive Officer, Senior Vice President of Legal and General Counsel at Neoleukin. Previously, Donna held various senior legal leadership roles in the industry.
News
Other IT executives who recently changed jobs as well: Cohen Andrew, Rickerson Stuart, Bauman Mary, Papa Salvatore, Jester Cole, Randazzo Renee, Liu Joey, Sebring Jason, Lagomarsine Jerry, Szymanski Theresa, Charkow Jason
You can find the full directory of IT executives here.
How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.